Daptomycin for the treatment of major gram-positive infections after cardiac surgery

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1749-8090

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Daptomycin for the treatment of major gram-positive infections after cardiac surgery ; volume:11 ; number:1 ; day:4 ; month:8 ; year:2016 ; pages:1-8 ; date:12.2016
Journal of cardiothoracic surgery ; 11, Heft 1 (4.8.2016), 1-8, 12.2016

Creator: Kornberger, A.

Contributor: Luchting, B.
Kur, F.
Weis, M.
Weis, F.
Stock, U. A.
Beiras-Fernandez, A.
SpringerLink (Online service)

DOI: 10.1186/s13019-016-0519-7

URN: urn:nbn:de:1111-20160901808

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Kornberger, A.
Luchting, B.
Kur, F.
Weis, M.
Weis, F.
Stock, U. A.
Beiras-Fernandez, A.
SpringerLink (Online service)

Other Objects (12)

Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-

Midterm results after treatment of gram-positive deep sternal wound infections with daptomycin for cardiac surgery patients

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien - ein Update

Oritavancin as sequential therapy for Gram-positive bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-

Midterm results after treatment of gram-positive deep sternal wound infections with daptomycin for cardiac surgery patients

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien - ein Update

Oritavancin as sequential therapy for Gram-positive bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-

Midterm results after treatment of gram-positive deep sternal wound infections with daptomycin for cardiac surgery patients

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien - ein Update

Oritavancin as sequential therapy for Gram-positive bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Daptomycin for the treatment of major gram-positive infections after cardiac surgery

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-

Midterm results after treatment of gram-positive deep sternal wound infections with daptomycin for cardiac surgery patients

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien - ein Update

Oritavancin as sequential therapy for Gram-positive bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-

Midterm results after treatment of gram-positive deep sternal wound infections with daptomycin for cardiac surgery patients

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien - ein Update

Oritavancin as sequential therapy for Gram-positive bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-

Midterm results after treatment of gram-positive deep sternal wound infections with daptomycin for cardiac surgery patients

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry

Daptomycin (Cubicin) : Stellenwert von Daptomycin bei Infektionen durch grampositive Bakterien - ein Update

Oritavancin as sequential therapy for Gram-positive bloodstream infections

CSF inflammatory markers differ in gram-positive versus gram-negative shunt infections

Real-World Evidence for Oritavancin Use in Gram-Positive Infections

Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections

Phage therapy as a revolutionary medicine against Gram-positive bacterial infections

Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria

Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections

Related objects

Reset password